1. Home
  2. OGN vs FOUR Comparison

OGN vs FOUR Comparison

Compare OGN & FOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • FOUR
  • Stock Information
  • Founded
  • OGN 1923
  • FOUR 1999
  • Country
  • OGN United States
  • FOUR United States
  • Employees
  • OGN N/A
  • FOUR N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • FOUR Business Services
  • Sector
  • OGN Health Care
  • FOUR Consumer Discretionary
  • Exchange
  • OGN Nasdaq
  • FOUR Nasdaq
  • Market Cap
  • OGN 4.0B
  • FOUR 4.5B
  • IPO Year
  • OGN N/A
  • FOUR 2020
  • Fundamental
  • Price
  • OGN $15.89
  • FOUR $116.19
  • Analyst Decision
  • OGN Hold
  • FOUR Buy
  • Analyst Count
  • OGN 3
  • FOUR 21
  • Target Price
  • OGN $21.33
  • FOUR $107.89
  • AVG Volume (30 Days)
  • OGN 4.3M
  • FOUR 1.2M
  • Earning Date
  • OGN 02-13-2025
  • FOUR 02-18-2025
  • Dividend Yield
  • OGN 7.06%
  • FOUR N/A
  • EPS Growth
  • OGN 120.97
  • FOUR 10.30
  • EPS
  • OGN 5.04
  • FOUR 1.87
  • Revenue
  • OGN $6,409,000,000.00
  • FOUR $3,149,000,000.00
  • Revenue This Year
  • OGN $3.29
  • FOUR $37.67
  • Revenue Next Year
  • OGN $1.93
  • FOUR $30.13
  • P/E Ratio
  • OGN $3.15
  • FOUR $61.98
  • Revenue Growth
  • OGN 4.21
  • FOUR 31.37
  • 52 Week Low
  • OGN $13.87
  • FOUR $55.87
  • 52 Week High
  • OGN $23.10
  • FOUR $116.85
  • Technical
  • Relative Strength Index (RSI)
  • OGN 55.80
  • FOUR 67.46
  • Support Level
  • OGN $15.52
  • FOUR $101.25
  • Resistance Level
  • OGN $16.23
  • FOUR $110.35
  • Average True Range (ATR)
  • OGN 0.53
  • FOUR 4.12
  • MACD
  • OGN 0.10
  • FOUR 0.87
  • Stochastic Oscillator
  • OGN 79.22
  • FOUR 96.48

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About FOUR Shift4 Payments Inc.

Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.

Share on Social Networks: